Skip to main content
1

10Fold

10Fold develops a patented, non‑invasive focused ultrasound system called 10Fold™ Technology to treat obesity and related metabolic diseases without surgery, drugs, implants, or restrictive diets. The platform delivers precise energy to reduce adipose tissue, offering a drug‑free alternative for patients seeking sustainable weight loss. By leveraging a unique ultrasound paradigm, 10Fold aims to provide a safe, outpatient solution that directly addresses the global obesity epidemic.

Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Obesity and related metabolic diseases affect a large portion of the population, and current treatments often rely on invasive surgery, long‑term drug regimens, implants, or strict dietary programs, which can be costly, carry side effects, and suffer from low patient adherence.

Solution

10FoldMed offers a non‑invasive, focused ultrasound system that targets and destroys visceral fat cells without incisions, drugs, or implants. The patented 10Fold™ technology uses a self‑guided, precision ultrasound device combined with machine‑learning algorithms to deliver energy selectively to adipose tissue, reducing fat volume and improving insulin resistance. The procedure is performed externally, requires no special diet, and aims to provide a drug‑free weight‑loss option for patients with obesity and metabolic disorders. By eliminating the need for surgical or pharmacological interventions, the solution seeks to lower treatment risk and improve long‑term health outcomes.

Target Audience

Primary customers are healthcare providers and weight‑management clinics treating adults with obesity and metabolic syndrome who seek non‑surgical, drug‑free therapeutic options.

Features

  • Patent‑pending focused ultrasound platform that non‑invasively ablates visceral fat cells
  • Self‑guided targeting system that uses real‑time imaging to ensure precise energy delivery
  • Integrated machine‑learning models to optimize treatment parameters for individual patients
  • No requirement for anesthesia, implants, or pharmacological agents
  • Procedure performed externally with minimal downtime and no special dietary restrictions
This profile is AI-generated and may contain inaccuracies.